CO6602166A2 - Composiciones de inhibidor virico para uso terapeutico in vivo que comprende una combinacion de (-)- carvona, geraniol y otro componente de aceite escencial - Google Patents
Composiciones de inhibidor virico para uso terapeutico in vivo que comprende una combinacion de (-)- carvona, geraniol y otro componente de aceite escencialInfo
- Publication number
- CO6602166A2 CO6602166A2 CO12162165A CO12162165A CO6602166A2 CO 6602166 A2 CO6602166 A2 CO 6602166A2 CO 12162165 A CO12162165 A CO 12162165A CO 12162165 A CO12162165 A CO 12162165A CO 6602166 A2 CO6602166 A2 CO 6602166A2
- Authority
- CO
- Colombia
- Prior art keywords
- carvone
- geraniol
- combination
- essential oil
- vivo
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente invención se refiere a una composición antivírica que comprende los siguientes componentes: R-(-)-2-metil-5-(prop-1-en-2-il)- ciclohex-2-enona (también llamada (-)-carvona) y S-(+)-2-metil-5-(prop-1-en-2- il)-ciclohex-2-enona (también llamada (÷)-carvona) y (2E)-3,7-dirnetilocta.-2,6- dien-1-ol (también llamado trans-geraniol) en combinación con al menos un componente más elegido entre componentes de aceites esenciales para su uso en el tratamiento y la prevención de enfermedades producidas por virus encapsulados de ADN, virus no encapsulados de ADN, virus encapsulados de ARN y virus no encapsulados de ARN.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10157930A EP2368547B1 (en) | 2010-03-26 | 2010-03-26 | Antiviral compositions comprising geraniol and carvone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6602166A2 true CO6602166A2 (es) | 2013-01-18 |
Family
ID=42102951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO12162165A CO6602166A2 (es) | 2010-03-26 | 2012-09-19 | Composiciones de inhibidor virico para uso terapeutico in vivo que comprende una combinacion de (-)- carvona, geraniol y otro componente de aceite escencial |
Country Status (35)
| Country | Link |
|---|---|
| US (2) | US8980945B2 (es) |
| EP (2) | EP2368547B1 (es) |
| JP (1) | JP5342085B2 (es) |
| KR (1) | KR101340260B1 (es) |
| CN (1) | CN102946876B (es) |
| AU (1) | AU2011231511B2 (es) |
| BR (1) | BR112012024260B1 (es) |
| CA (1) | CA2790087C (es) |
| CL (1) | CL2012002606A1 (es) |
| CO (1) | CO6602166A2 (es) |
| CY (3) | CY1113449T1 (es) |
| DK (2) | DK2368547T3 (es) |
| EA (1) | EA025278B9 (es) |
| ES (2) | ES2392938T3 (es) |
| HK (1) | HK1176019A1 (es) |
| HR (2) | HRP20120964T1 (es) |
| HU (1) | HUE026121T2 (es) |
| IL (1) | IL222048A (es) |
| LU (1) | LU91805B1 (es) |
| MA (1) | MA34074B1 (es) |
| ME (1) | ME02035B (es) |
| MX (1) | MX346412B (es) |
| MY (2) | MY153104A (es) |
| NZ (1) | NZ602602A (es) |
| PE (2) | PE20130065A1 (es) |
| PL (2) | PL2368547T3 (es) |
| PT (2) | PT2368547E (es) |
| RS (2) | RS52544B (es) |
| SG (1) | SG184039A1 (es) |
| SI (2) | SI2368547T1 (es) |
| SM (2) | SMT201200062B (es) |
| TN (2) | TN2012000444A1 (es) |
| UA (1) | UA102497C2 (es) |
| WO (1) | WO2011117424A1 (es) |
| ZA (2) | ZA201208116B (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9693941B2 (en) | 2011-11-03 | 2017-07-04 | Conopco, Inc. | Liquid personal wash composition |
| EP2787825B2 (en) | 2011-12-06 | 2021-11-03 | Unilever Global IP Limited | Antimicrobial composition |
| EP2787828B1 (en) | 2011-12-06 | 2016-09-07 | Unilever N.V. | Antimicrobial composition |
| CN104023539B (zh) | 2011-12-06 | 2021-08-13 | 联合利华知识产权控股有限公司 | 抗微生物组合物 |
| IN2014MN02378A (es) | 2012-06-27 | 2015-08-14 | Unilever Plc | |
| RU2533254C2 (ru) * | 2012-12-29 | 2014-11-20 | Федеральное государственное бюджетное учреждение научно-исследовательский институт детских инфекций Федерального медико-биологического агентства | Способ лечения неврологических осложнений при ветряной оспе у детей |
| TWI463979B (zh) * | 2013-04-12 | 2014-12-11 | Nat Defense Medical Ct | 檸檬醛用於製備治療局部腎絲球硬化症之藥物的用途 |
| KR20150145314A (ko) | 2014-06-18 | 2015-12-30 | 원광대학교산학협력단 | 카르본을 유효성분으로 포함하는 항균 조성물 |
| CN106727628A (zh) * | 2016-12-17 | 2017-05-31 | 郑州郑先医药科技有限公司 | 一种治疗慢性腹泻的西药组合物 |
| KR101970281B1 (ko) * | 2017-07-28 | 2019-04-18 | 고려대학교 산학협력단 | 리나릴 아세테이트를 포함하는 올메사탄으로 유발된 장운동과다증의 예방 또는 치료용 조성물 |
| CN107648488A (zh) * | 2017-09-29 | 2018-02-02 | 陈晓阳 | 一种用于治疗慢性咽炎的丸剂 |
| KR102118181B1 (ko) * | 2018-06-12 | 2020-06-02 | 광주여자대학교 산학협력단 | 식물성 정유를 유효성분으로 포함하는 a형 인플루엔자 바이러스에 대한 항바이러스 조성물 |
| RU2707950C1 (ru) * | 2018-11-28 | 2019-12-02 | Общество с ограниченной ответственностью "ЭРБИ" | Средство для обработки среды пребывания птицы на основе липосом с фитокомпозицией с иммунотропным действием и избирательным антисептическим эффектом и способ его применения |
| US20200179299A1 (en) * | 2018-12-07 | 2020-06-11 | Global Biolife Inc. | Composition and method of controlling infectious diseases with functional fragrances |
| CN110496117B (zh) * | 2019-09-30 | 2022-09-06 | 中国科学院微生物研究所 | 一种小分子化合物在抗非洲猪瘟病毒感染中的新应用 |
| CN111012769B (zh) * | 2019-12-05 | 2021-02-12 | 青海大学 | 一种用于治疗包虫病的药物组合物、药物制剂及乳剂制备方法 |
| SG10201914042SA (en) * | 2019-12-31 | 2021-07-29 | Xj Bio Engineering Int Pte Ltd | Feed additive for preventing african swine fever disease or replacing antibiotic growth promoters and methods of making and using the same |
| WO2021224947A1 (en) * | 2020-05-02 | 2021-11-11 | Norouzi Mehdi | Formulation of acute respiratory disease control formulation |
| CN114702376A (zh) * | 2020-12-14 | 2022-07-05 | 中南民族大学 | 柏木醇衍生物、其制备方法及其应用 |
| CA3102947A1 (en) * | 2020-12-18 | 2022-06-18 | Skymount Medical Us Inc. | Nutraceuticals useful in the treatment of coronavirus diseases |
| CN115141681B (zh) * | 2021-03-30 | 2024-06-21 | 湖南诺泽生物科技有限公司 | 挥发油、其制备方法及用途 |
| JP7133820B1 (ja) | 2021-06-09 | 2022-09-09 | 塩野香料株式会社 | コロナウイルス感染症予防用香料組成物及び結合阻害剤 |
| CN113994963B (zh) * | 2021-09-26 | 2023-04-28 | 中国农业科学院烟草研究所(中国烟草总公司青州烟草研究所) | 一种含有乙酸二氢香芹酯的抑芽剂及其用途 |
| TWI800937B (zh) * | 2021-10-01 | 2023-05-01 | 奇美醫療財團法人奇美醫院 | 用於治療登革熱病毒感染之方法 |
| WO2024097158A1 (en) * | 2022-11-01 | 2024-05-10 | Ramirez Christina M | Viral prophylaxis treatment methods and pre-exposure prophylaxis kits |
| CN117338758B (zh) * | 2023-12-06 | 2024-03-12 | 北京远大九和药业有限公司 | 一种药物组合物及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR5667M (es) | 1966-03-10 | 1968-01-02 | ||
| LU78955A1 (de) | 1978-01-27 | 1979-09-06 | Chimicasa Gmbh | Verfahren zur inaktivierung von viren |
| US4902678A (en) * | 1982-02-12 | 1990-02-20 | Syntex (U.S.A.) Inc. | Anti-viral compositions |
| US5856364A (en) * | 1991-03-01 | 1999-01-05 | Warner Lambert Company | Therapeutic antiviral-wound healing compositions and methods for preparing and using same |
| US5716928A (en) * | 1995-06-07 | 1998-02-10 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
| WO2002056879A1 (en) * | 2001-01-03 | 2002-07-25 | Medpharma Plc | Use of terpenes for the treatment of digestive tract infections |
| US20040071757A1 (en) * | 2001-11-20 | 2004-04-15 | David Rolf | Inhalation antiviral patch |
| US9439416B2 (en) * | 2005-11-30 | 2016-09-13 | Eden Research Plc | Compositions and methods comprising terpenes or terpene mixtures selected from thymol, eugenol, geraniol, citral, and l-carvone |
| US9403126B2 (en) * | 2007-01-10 | 2016-08-02 | The Regents Of The University Of Michigan | Ultrafiltration membrane, device, bioartificial organ, and related methods |
| KR100796312B1 (ko) * | 2007-05-23 | 2008-01-21 | 주식회사 바이오미스트테크놀로지 | 게라니얼，네랄 및 유게놀을 유효성분으로 함유하는 동물용소독제 조성물 |
| KR100950428B1 (ko) | 2008-06-05 | 2010-04-02 | 주식회사 알앤엘바이오 | 바이러스 억제제로서 유용한 디아릴헵타노이드계 화합물 |
| KR100941595B1 (ko) | 2008-06-05 | 2010-02-11 | 주식회사 알앤엘바이오 | 바이러스 억제제로서 유용한 트리테르페노이드계 화합물 |
-
2010
- 2010-03-26 EP EP10157930A patent/EP2368547B1/en active Active
- 2010-03-26 ME MEP-2012-533A patent/ME02035B/me unknown
- 2010-03-26 RS RS20120533A patent/RS52544B/en unknown
- 2010-03-26 DK DK10157930.8T patent/DK2368547T3/da active
- 2010-03-26 PT PT10157930T patent/PT2368547E/pt unknown
- 2010-03-26 ES ES10157930T patent/ES2392938T3/es active Active
- 2010-03-26 PL PL10157930T patent/PL2368547T3/pl unknown
- 2010-03-26 SI SI201030084T patent/SI2368547T1/sl unknown
-
2011
- 2011-03-28 ES ES11710232.7T patent/ES2486765T3/es active Active
- 2011-03-28 CN CN201180026050.1A patent/CN102946876B/zh active Active
- 2011-03-28 NZ NZ602602A patent/NZ602602A/xx unknown
- 2011-03-28 LU LU91805A patent/LU91805B1/fr active
- 2011-03-28 US US13/582,784 patent/US8980945B2/en active Active
- 2011-03-28 UA UAA201212244A patent/UA102497C2/ru unknown
- 2011-03-28 DK DK11710232.7T patent/DK2555763T3/da active
- 2011-03-28 KR KR1020127027321A patent/KR101340260B1/ko active IP Right Grant
- 2011-03-28 JP JP2013500539A patent/JP5342085B2/ja active Active
- 2011-03-28 MX MX2012010949A patent/MX346412B/es active IP Right Grant
- 2011-03-28 BR BR112012024260A patent/BR112012024260B1/pt active IP Right Grant
- 2011-03-28 EA EA201270749A patent/EA025278B9/ru unknown
- 2011-03-28 SG SG2012067724A patent/SG184039A1/en unknown
- 2011-03-28 PL PL11710232T patent/PL2555763T3/pl unknown
- 2011-03-28 EP EP11710232.7A patent/EP2555763B1/en active Active
- 2011-03-28 PT PT117102327T patent/PT2555763E/pt unknown
- 2011-03-28 WO PCT/EP2011/054758 patent/WO2011117424A1/en active Application Filing
- 2011-03-28 MY MYPI2012004074 patent/MY153104A/en unknown
- 2011-03-28 CA CA2790087A patent/CA2790087C/en active Active
- 2011-03-28 RS RS20140380A patent/RS53435B/en unknown
- 2011-03-28 AU AU2011231511A patent/AU2011231511B2/en active Active
- 2011-03-28 SI SI201130216T patent/SI2555763T1/sl unknown
- 2011-03-28 MA MA35226A patent/MA34074B1/fr unknown
- 2011-03-28 PE PE2012001578A patent/PE20130065A1/es active IP Right Grant
- 2011-09-27 PE PE2013002126A patent/PE20141008A1/es active IP Right Grant
- 2011-09-27 MY MYPI2013003352A patent/MY158757A/en unknown
- 2011-09-27 HU HUE11761085A patent/HUE026121T2/en unknown
-
2012
- 2012-09-12 TN TNP2012000444A patent/TN2012000444A1/en unknown
- 2012-09-19 CO CO12162165A patent/CO6602166A2/es not_active Application Discontinuation
- 2012-09-20 IL IL222048A patent/IL222048A/en active IP Right Grant
- 2012-09-21 CL CL2012002606A patent/CL2012002606A1/es unknown
- 2012-10-26 ZA ZA2012/08116A patent/ZA201208116B/en unknown
- 2012-11-27 HR HRP20120964AT patent/HRP20120964T1/hr unknown
- 2012-12-10 CY CY20121101200T patent/CY1113449T1/el unknown
- 2012-12-24 SM SM201200062T patent/SMT201200062B/xx unknown
-
2013
- 2013-03-21 HK HK13103557.4A patent/HK1176019A1/xx unknown
- 2013-09-16 TN TNP2013000366A patent/TN2013000366A1/fr unknown
- 2013-09-16 ZA ZA2013/06926A patent/ZA201306926B/en unknown
-
2014
- 2014-07-14 US US14/331,131 patent/US8883859B1/en active Active
- 2014-07-22 HR HRP20140706AT patent/HRP20140706T1/hr unknown
- 2014-07-29 CY CY20141100573T patent/CY1115375T1/el unknown
- 2014-07-31 SM SM201400104T patent/SMT201400104B/xx unknown
-
2015
- 2015-05-29 CY CY20151100478T patent/CY1119841T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6602166A2 (es) | Composiciones de inhibidor virico para uso terapeutico in vivo que comprende una combinacion de (-)- carvona, geraniol y otro componente de aceite escencial | |
| CY1121572T1 (el) | Σκευασμα δισκιου του ν-[2,4-δις(1,1-διμεθυλαιθυλ)-5-υδροξυφαινυλ]-1,4-διυδρο-4-οξοκινολινο-3-καρβοξαμιδιου για χρηση στη θεραπεια κυστικης ινωσης | |
| CY1123901T1 (el) | Φαρμακευτικη συνθεση και χορηγησεις αυτης | |
| ECSP14013315A (es) | Inhibidores de aplicación viral | |
| CO6571891A2 (es) | Inhibidores del virus de la hepatitis c. | |
| ECSP099685A (es) | Compuestos de azufre como inhibidores de la serina proteasa ns3 del virus de la hepatitis c | |
| CL2012003226A1 (es) | Compuestos derivados de 5-fluoro-1h-pirazolopiridina ; procedimiento de preparacion de estos; composicion framaceutica que los comprende; y su uso en el tratamiento de enfermedades cardiovasculares, sexuales y metabolicas. | |
| UY31170A1 (es) | Compuestos moduladores de sirtuina | |
| CO6470821A2 (es) | Pirazinilpirazoles | |
| BR112015001313A2 (pt) | composições de vacina | |
| GT200600144AA (es) | 1h-quinazolin-2,4-dionas (solicitud fraccionaria, derivada de la solicitud de patente de invencion pi-2006-00144) | |
| DOP2014000034A (es) | Compuestos de benzofurano para su uso en el tratamiento de infecciones por el virus de hepatitis c (hcv) | |
| EA201290373A1 (ru) | Синергическая противовирусная композиция и ее применение | |
| BR112013032049A2 (pt) | inibidores do vírus da hepatite c | |
| UY33530A (es) | Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias | |
| CL2017001275A1 (es) | Análogos ligados de urea sustituidos como moduladores de sirtuina | |
| BR112015007879A2 (pt) | inibidores do vírus da hepatite c | |
| AR084187A1 (es) | Composiciones para el cuidado oral | |
| CO6280474A2 (es) | Composicion farmaceutica para el tratamiento de la eyaculacion precoz | |
| BR112012022209A2 (pt) | composições farmacêuticas compreendendo monoterpenos | |
| UY30653A1 (es) | Antiinflamatorios no esteroideos contra la tos | |
| CO6771455A2 (es) | Composición de inhibidor vírico para uso terapéutico in vivo | |
| UY35101A (es) | Composiciones plaguicidas y métodos para el control de plagas de invertebrados. | |
| CL2013002761A1 (es) | Uso de composicion farmaceutica que comprende catecoles (1,2-dihidroxibencenos) 3,5 disustituidos, util para el tratamiento de enfermedades causadas por virus de adn o arn (no) encapsulados. | |
| TH131426B (th) | องค์ประกอบสารยับยั้งไวรัส (Viral inhibitor composition) สำหรับการใช้รักษา โรคภายในสิ่งมีชีวิตที่ประกอบด้วยการรวมของ (-)-คาร์โวน, (+)-คาร์โวน (Carvone), เจรานิออล (Geraniol) และ ส่วนประกอบน้ำมันที่จำเป็นนอกจากนี้ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |